頸動脈および腎動脈ステント市場：パイプラインレポート（開発段階、セグメント、地域・国、規制経路、主要企業）、2024最新版

頸動脈ステントは、血液の流れを良くするために狭窄した頸動脈に留置される拡張可能なチューブです。頸動脈は、動脈の内表面にプラークが形成・蓄積されることにより狭くなります。

当レポートでは、頸動脈および腎動脈ステント市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

• 頸動脈および腎動脈ステントの概要

第3章 開発中の製品

• 頸動脈および腎動脈ステント - 開発段階別パイプライン製品
• 頸動脈および腎動脈ステント - セグメント別パイプライン製品
• 頸動脈および腎動脈ステント - 地域別パイプライン製品
• 頸動脈および腎動脈ステント - 規制経路別パイプライン製品
• 頸動脈および腎動脈ステント - 推定承認日別パイプライン製品
• 頸動脈および腎動脈ステント - 進行中の臨床試験

第4章 頸動脈・腎動脈ステント- 各社開発中のパイプライン製品

• 頸動脈および腎動脈ステント企業- 開発段階別のパイプライン製品
• 頸動脈および腎動脈ステント- 開発段階別のパイプライン製品

第5章 頸動脈および腎動脈ステントの企業と製品の概要

• Acotec Scientific Holdings Ltd
• CR Bard Inc
• Evasc Medical Systems Corp
• InspireMD Inc
• Loyola University Chicago
• MicroPort Scientific Corp
• Nesstent Ltd.
• Palmaz Scientific Inc
• Shanghai HeartCare Medical Technology Co Ltd
• SurModics Inc

第6章 頸動脈および腎動脈ステント-最近の動向

第7章 付録

List of Tables

• Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
• Carotid and Renal Artery Stents - Pipeline Products by Segment
• Carotid and Renal Artery Stents - Pipeline Products by Territory
• Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
• Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
• Carotid and Renal Artery Stents - Ongoing Clinical Trials
• Carotid and Renal Artery Stents Companies - Pipeline Products by Stage of Development
• Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
• Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Carotid Stent - Product Status
• Carotid Stent - Product Description
• CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
• VIVEXX Carotid Stent - Product Status
• VIVEXX Carotid Stent - Product Description
• Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
• ROSS - Renal Ostial Stent System - Product Status
• ROSS - Renal Ostial Stent System - Product Description
• InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
• CGuard Embolic Prevention System - Product Status
• CGuard Embolic Prevention System - Product Description
• Next Gen CGuard - 5F - Product Status
• Next Gen CGuard - 5F - Product Description
• RGuard Renal - Product Status
• RGuard Renal - Product Description
• InspireMD Inc - Ongoing Clinical Trials Overview
• CGuard Embolic Prevention System - Acute Stroke of Carotid Artery Bifurcation Origin Treated with Use of the Micronet-covered CGUARD Stent Under Transient Flow Reversal Linked with Thrombus Retrieval: SAFEGUARD-STROKE Study
• CGuard Embolic Prevention System - An Early Feasibility Study (EFS) Assessing the CGuard Embolic Prevention Carotid Stent to Treat Severe Carotid Stenosis or Occlusion
• CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
• CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
• Loyola University Chicago Pipeline Products & Ongoing Clinical Trials Overview
• Intravascular Stent - Product Status
• Intravascular Stent - Product Description
• MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• Taurus Carotid Stent - Product Status
• Taurus Carotid Stent - Product Description
• Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• NesStent's Stent - Carotid Bifurcation - Product Status
• NesStent's Stent - Carotid Bifurcation - Product Description
• Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• Micro-Mesh Covered Carotid Stent - Product Status
• Micro-Mesh Covered Carotid Stent - Product Description
• Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Carotid Artery Stent - Product Status
• Carotid Artery Stent - Product Description
• Shanghai HeartCare Medical Technology Co Ltd - Ongoing Clinical Trials Overview
• Carotid Artery Stent - The Safety and Efficacy of Carotid Artery Stenting in Carotid Stenosis: A Prospective Multicenter, Non-inferiority Design, Randomized, Controlled Clinical Trial
• SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
• Renal Stent System - Product Status
• Renal Stent System - Product Description
• Glossary

List of Figures

• Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
• Carotid and Renal Artery Stents - Pipeline Products by Segment
• Carotid and Renal Artery Stents - Pipeline Products by Territory
• Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
• Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
• Carotid and Renal Artery Stents - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Carotid and Renal Artery Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Carotid and Renal Artery Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Carotid and Renal Artery Stents under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Carotid and Renal Artery Stents and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Carotid and Renal Artery Stents under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Carotid and Renal Artery Stents Overview

3 Products under Development

• 3.1 Carotid and Renal Artery Stents - Pipeline Products by Stage of Development
• 3.2 Carotid and Renal Artery Stents - Pipeline Products by Segment
• 3.3 Carotid and Renal Artery Stents - Pipeline Products by Territory
• 3.4 Carotid and Renal Artery Stents - Pipeline Products by Regulatory Path
• 3.5 Carotid and Renal Artery Stents - Pipeline Products by Estimated Approval Date
• 3.6 Carotid and Renal Artery Stents - Ongoing Clinical Trials

4 Carotid and Renal Artery Stents - Pipeline Products under Development by Companies

• 4.1 Carotid and Renal Artery Stents Companies - Pipeline Products by Stage of Development
• 4.2 Carotid and Renal Artery Stents - Pipeline Products by Stage of Development

5 Carotid and Renal Artery Stents Companies and Product Overview

• 5.1 Acotec Scientific Holdings Ltd Company Overview
  • 5.1.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 CR Bard Inc Company Overview
  • 5.2.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Evasc Medical Systems Corp Company Overview
  • 5.3.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 InspireMD Inc Company Overview
  • 5.4.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Loyola University Chicago Company Overview
  • 5.5.1 Loyola University Chicago Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 MicroPort Scientific Corp Company Overview
  • 5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Nesstent Ltd. Company Overview
  • 5.7.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Palmaz Scientific Inc (Inactive) Company Overview
  • 5.8.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Shanghai HeartCare Medical Technology Co Ltd Company Overview
  • 5.9.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 SurModics Inc Company Overview
  • 5.10.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Carotid and Renal Artery Stents- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer